NEUROPATHIX Trademark

Trademark Overview


On Thursday, July 23, 2020, a trademark application was filed for NEUROPATHIX with the United States Patent and Trademark Office. The USPTO has given the NEUROPATHIX trademark a serial number of 90069642. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 1, 2022. This trademark is owned by Kannalife, Inc.. The NEUROPATHIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the prevention of chronic and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of chronic and neuropathic pain; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of chronic and neuropathic pain; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical prepa...

Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research in the field of chronic and neuropathic pain
neuropathix

General Information


Serial Number90069642
Word MarkNEUROPATHIX
Filing DateThursday, July 23, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the prevention of chronic and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of chronic and neuropathic pain; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of chronic and neuropathic pain; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Digestives for pharmaceutical purposes; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Plant extracts for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Therapeutic pharmaceutical for the treatment of chronic and neuropathic pain
Goods and ServicesPharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research in the field of chronic and neuropathic pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKannalife, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDoylestown, PA 18902

Trademark Events


Event DateEvent Description
Tuesday, March 1, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, March 1, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 12, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 12, 2021FINAL REFUSAL E-MAILED
Thursday, August 12, 2021FINAL REFUSAL WRITTEN
Thursday, July 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 9, 2021ASSIGNED TO LIE
Wednesday, May 26, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, May 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 25, 2021PETITION TO REVIVE-GRANTED
Tuesday, May 25, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, November 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 23, 2020NON-FINAL ACTION E-MAILED
Monday, November 23, 2020NON-FINAL ACTION WRITTEN
Thursday, November 12, 2020ASSIGNED TO EXAMINER
Monday, November 9, 2020ASSIGNED TO EXAMINER
Monday, November 9, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 27, 2020NEW APPLICATION ENTERED